Evaluation of Predict, a prognostic risk tool, after diagnosis of a second breast cancer

BACKGROUND: The UK National Health Service’s Predict is a clinical tool widely used to estimate the prognosis of early-stage breast cancer. The performance of Predict for a second primary breast cancer is unknown. METHODS: Women 18 years of age or older diagnosed with a first or second invasive brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zhengyi, Jones, Miranda R, Wolff, Antonio C, Visvanathan, Kala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660126/
https://www.ncbi.nlm.nih.gov/pubmed/37773987
http://dx.doi.org/10.1093/jncics/pkad081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660126/
https://www.ncbi.nlm.nih.gov/pubmed/37773987
http://dx.doi.org/10.1093/jncics/pkad081

Ejemplares similares